Men with prostate cancer are being given false hope by tests that underestimate the aggressiveness of their disease, a study suggests.
Researchers found that more than half of a group of men whose cancers were initially classified as slow-growing and confined turned out to have more dangerous tumours.
The findings, published in the British Journal Of Cancer, call into question the ability of experts to grade and stage prostate cancers on the basis of biopsy samples.
It also casts doubt on the "active surveillance" strategy of avoiding unnecessary radical treatment for patients with slow-growing prostate cancer.
Instead, these patients are often closely monitored but left alone until tests suggest their condition has worsened.
More top news
Celebrities including Chris Evans and Joanna Lumley are expected to attend the event marking 50 years since the broadcaster went on air
Staging a 'feast in a cemetery' is an important date in the calendar of one of Europe’s last surviving ethnic folk cultures, the Setos.
What was the reaction online to the first presidential debate that saw Clinton and Trump go head-to-head?